Literature DB >> 29844571

Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.

Chun-Peng Liao1,2,3, Tzu-Ping Lin1,2,4, Pei-Chuan Li1,2, Lauren A Geary1,2, Kevin Chen1,2, Vijaya Pooja Vaikari1,2, Jason Boyang Wu5, Chi-Hung Lin4, Mitchell E Gross3,6, Jean C Shih7,8,9,10,11.   

Abstract

Monoamine oxidase A (MAOA) is a mitochondrial enzyme, which degrades monoamine neurotransmitters and dietary amines and produces H2O2. Recent studies have shown increased MAOA expression in prostate cancer (PCa), glioma, and classical Hodgkin lymphoma. However, the biological function of MAOA in cancer development remains unknown. In this study, we investigated the role of MAOA in the development of prostate adenocarcinoma by creating a prostate-specific Pten/MAOA knockout (KO) mouse model, in which MAOA-floxP mouse was crossed with the conditional Pten KO PCa mouse that develops invasive PCa. In contrast to Pten KO mice, age-matched Pten/MAOA KO mice exhibited a significant decrease in both prostate size and the incidence of invasive cancer. We observed a significant decline in AKT phosphorylation and Ki67 expression in Pten/MAOA KO mice, which reduced epithelial cell growth and proliferation. As cancer stem cells (CSCs) are required for tumor initiation and growth, we investigated expression of OCT4 and NANOG in the setting of decreased MAOA expression. We found that both OCT4 and NANOG were significantly attenuated in the prostate epithelia of Pten/MAOA KO mice compared to Pten KO mice, which was confirmed with targeted knockdown of MAOA with a short-hairpin(sh) vector targeting MAOA compared to cells transfected with a control vector. Expression of other markers associated with the a stem cell phenotype, including CD44, α2β1, and CD133 as well as HIF-1α+CD44+ stem cells were all decreased in shMAOA PCa cells compared with empty vector-transfected control cells. We also found spheroid formation ability in PCa cells was decreased when endogenous MAOA was suppressed by siRNA or MAOA inhibitor clorgyline in a colony formation assay. Using the TCGA database, elevated MAOA expression was associated with reduced Pten levels in high Gleason grade in patient samples. Further, we found that Pten-positive PCa cells were more resistant to clorgyline treatments than Pten-null cells in tumorigenicity and stemness. Taken together, these studies suggest that MAOA expression promotes PCa development by increasing cell proliferation and CSCs and highlights the potential use of MAOA inhibitors for the treatment of PCa.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29844571     DOI: 10.1038/s41388-018-0325-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Tyrosine residues near the FAD binding site are critical for FAD binding and for the maintenance of the stable and active conformation of rat monoamine oxidase A.

Authors:  Jichun Ma; Akio Ito
Journal:  J Biochem       Date:  2002-01       Impact factor: 3.387

3.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

4.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Subtle variations in Pten dose determine cancer susceptibility.

Authors:  Andrea Alimonti; Arkaitz Carracedo; John G Clohessy; Lloyd C Trotman; Caterina Nardella; Ainara Egia; Leonardo Salmena; Katia Sampieri; William J Haveman; Edi Brogi; Andrea L Richardson; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Authors:  Chun-Peng Liao; Helty Adisetiyo; Mengmeng Liang; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

Review 7.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 8.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

9.  Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium.

Authors:  Yong Fu; Shiuan Wey; Miao Wang; Risheng Ye; Chun-Peng Liao; Pradip Roy-Burman; Amy S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

10.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more
  14 in total

1.  Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.

Authors:  Shikha Gaur; Mitchell E Gross; Chun-Peng Liao; Bin Qian; Jean C Shih
Journal:  Prostate       Date:  2019-01-28       Impact factor: 4.104

Review 2.  Cancer progression and the invisible phase of metastatic colonization.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2020-10-06       Impact factor: 60.716

Review 3.  Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.

Authors:  Jean C Shih
Journal:  J Neural Transm (Vienna)       Date:  2018-09-27       Impact factor: 3.575

4.  Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma.

Authors:  Toshihide Nishimura; Haruhiko Nakamura; Ayako Yachie; Takeshi Hase; Kiyonaga Fujii; Hirotaka Koizumi; Saeko Naruki; Masayuki Takagi; Yukiko Matsuoka; Naoki Furuya; Harubumi Kato; Hisashi Saji
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma.

Authors:  Hui Min Lee; Alice Pei Eal Sia; Lili Li; Hans Prakash Sathasivam; Melissa Sue Ann Chan; Pathmanathan Rajadurai; Chi Man Tsang; Sai Wah Tsao; Paul G Murray; Qian Tao; Ian C Paterson; Lee Fah Yap
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

6.  Monoamine Oxidase A is a Major Mediator of Mitochondrial Homeostasis and Glycolysis in Gastric Cancer Progression.

Authors:  Ling Chen; Li Guo; Ziwen Sun; Guochun Yang; Jing Guo; Kai Chen; Ruixue Xiao; Xigui Yang; Lijun Sheng
Journal:  Cancer Manag Res       Date:  2020-09-04       Impact factor: 3.989

Review 7.  The Role of Serotonin in Breast Cancer Stem Cells.

Authors:  William D Gwynne; Mirza S Shakeel; Adele Girgis-Gabardo; John A Hassell
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

8.  The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.

Authors:  Keliang Wang; Jie Luo; Shuyuan Yeh; Bosen You; Jialin Meng; Philip Chang; Yuanjie Niu; Gonghui Li; Changxue Lu; Yezi Zhu; Emmanuel S Antonarakis; Jun Luo; Chi-Ping Huang; Wanhai Xu; Chawnshang Chang
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

9.  Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.

Authors:  William D Gwynne; Mirza S Shakeel; Jianhan Wu; Robin M Hallett; Adele Girgis-Gabardo; Anna Dvorkin-Gheva; John A Hassell
Journal:  Cell Mol Biol Lett       Date:  2019-11-12       Impact factor: 5.787

10.  The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.

Authors:  Yu-Yan Pang; Jian-Di Li; Li Gao; Xia Yang; Yi-Wu Dang; Ze-Feng Lai; Li-Min Liu; Jie Yang; Hua-Yu Wu; Rong-Quan He; Zhi-Guang Huang; Dan-Dan Xiong; Li-Hua Yang; Lin Shi; Wei-Jia Mo; Deng Tang; Hui-Ping Lu; Gang Chen
Journal:  Cancer Med       Date:  2020-09-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.